“IL-2, IFN-?³ and anti-HBs based Immune Responses to Hepatitis B Vaccine in Type 2 Diabetic Patients” (2016) Journal of Medicine, 17(1), pp. 8–11. doi:10.3329/jom.v17i1.30051.